Thousand Oaks, CA, United States of America

Gabrielle St- Pierre

This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabrielle St- Pierre. Retrieved from https://idiyas.com/inventor/gabrielle-st-pierre-sek2091u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gabrielle St- Pierre: Innovator in Chemical Synthesis

Introduction

Gabrielle St- Pierre is a notable inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of chemical synthesis, particularly in the development of intermediates useful for pharmaceutical applications. Her work is characterized by a focus on innovative processes that enhance the efficiency of drug development.

Latest Patents

Gabrielle holds 1 patent for her invention titled "Synthesis of vinyl cyclobutyl intermediates." This patent outlines processes for synthesizing intermediates that are essential in preparing Mcl-1 inhibitors. Specifically, the patent details methods for synthesizing compound F, or a salt thereof, which can be instrumental in the synthesis of compound A1 and compound A2, or their respective salts or solvates.

Career Highlights

Gabrielle is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to drug development. Her role at Amgen allows her to apply her expertise in chemical synthesis to real-world challenges in the pharmaceutical industry.

Collaborations

Gabrielle collaborates with her coworker, Austin G Smith, to further advance their research and development efforts. Their partnership exemplifies the importance of teamwork in driving innovation within the field.

Conclusion

Gabrielle St- Pierre's contributions to chemical synthesis and her innovative patent work highlight her role as a key figure in the biotechnology sector. Her dedication to advancing pharmaceutical processes continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…